Schedule 13G ownership disclosure
MERUS N V
Common Shares, EUR0.09 nominal value per share · CUSIP: N5749R100
Event date: 2025-04-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Paradigm BioCapital Advisors LP
Shares: 3,554,059.00 · Class: 5.1%
- Paradigm BioCapital Advisors GP LLC
Shares: 3,554,059.00 · Class: 5.1%
- Senai Asefaw, M.D.
Shares: 3,554,059.00 · Class: 5.1%
- Paradigm BioCapital International Fund Ltd.
Shares: 3,150,225.00 · Class: 4.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-033766
- Form type
- SCHEDULE 13G
- Filer
- Merus N.V.
- CIK
- CIK 1651311
- Filed
- Apr 10, 2025
- Reporting period
- Apr 03, 2025
- Description
- Schedule 13G beneficial ownership